Kisqali Prices, Coupons and Patient Assistance Programs
Kisqali (ribociclib) is a member of the CDK 4/6 inhibitors drug class and is commonly used for Breast Cancer and Breast Cancer - Metastatic.
Kisqali Prices
This Kisqali price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Kisqali oral tablet 200 mg is around $5,001 for a supply of 21 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Kisqali is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Kisqali availability.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 21 | $238.12 | $5,000.55 |
| 42 (3 x 14 each) | $237.93 | $9,993.05 |
| 63 (3 x 21 each) | $198.24 | $12,489.30 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Kisqali Coupons and Rebates
Kisqali offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Kisqali Universal Co-Pay Card: Eligible patients may pay no more than $25 for each of your prescriptions with a maximum savings of $15,000 per calendar year; for additional information contact the program at 877-577-7756.
| Applies to: | Kisqali |
| Number of uses: | Per prescription until program expires |
| Expires | December 31, 2018 |
Patient Assistance Programs for Kisqali
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Novartis Patient Assistance Foundation, Inc.
Elligibility requirements:
- Must have no prescription coverage
- Not disclosed
- Not specified
- The patient must also be a US resident.
- For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the physician. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
- Kisqali (ribociclib)
- Kisqali Femara (ribociclib-letrozole) Tablet; Co-Pack
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Kisqali (ribociclib)
- Kisqali Femara (ribociclib-letrozole) Tablet; Co-Pack
Provider: PANO (Novartis Patient Assistance Now Oncology)
Elligibility requirements:
- Must have no prescription coverage
- Not disclosed
- Not specified
- The patient must also be a US resident.
- Eligibility determined on a case-by-case basis. Uninsured patients, call 1-866-884-5906 Patients with insurance, call 1-800-282-7630 This program also provides copay assistance up to $36,000 per year for Signifor and $9,600 per year for Sandostatin. Carcinoid tumor patients are now eligible.
Applicable drugs:
- Kisqali (ribociclib)
- Kisqali Femara (ribociclib-letrozole) Tablet; Co-Pack
More about Kisqali (ribociclib)
- Kisqali Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: CDK 4/6 inhibitors
